CA Stock MarketDetailed Quotes

HBP Helix BioPharma Corp

Watchlist
  • 1.290
  • +0.030+2.38%
15min DelayTrading Sep 4 11:52 ET
63.24MMarket Cap-6615P/E (TTM)

Helix BioPharma Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
(FY)Jul 31, 2022
(Q4)Jul 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-46.62%710K
-95.75%120K
-62.68%1.64M
-75.15%808K
-75.15%808K
-29.33%1.33M
499.58%2.82M
134.76%4.4M
-8.78%3.25M
-8.78%3.25M
-Cash and cash equivalents
-46.62%710K
-95.75%120K
-62.68%1.64M
-75.15%808K
-75.15%808K
-29.33%1.33M
499.58%2.82M
134.76%4.4M
-8.78%3.25M
-8.78%3.25M
Total current assets
-28.37%1.11M
-90.31%306K
-61.07%1.85M
-73.04%996K
-73.04%996K
-32.48%1.55M
250.11%3.16M
109.87%4.76M
-8.04%3.7M
-8.04%3.7M
Non current assets
-Accumulated depreciation
-0.84%-1.8M
-0.78%-1.8M
----
-0.67%-1.79M
-0.67%-1.79M
-0.68%-1.79M
-0.73%-1.79M
-0.73%-1.78M
-0.74%-1.78M
-0.74%-1.78M
-Other intangible assets
-68.31%2M
-68.56%2.49M
-60.35%3.72M
-57.83%4.36M
-57.83%4.36M
-64.73%6.31M
-60.37%7.9M
-52.39%9.38M
-47.36%10.34M
-47.36%10.34M
Regulatory assets
-22.81%88K
-39.05%64K
-53.69%69K
-77.78%62K
-77.78%62K
-67.34%114K
-67.08%105K
-51.78%149K
-20.96%279K
-20.96%279K
Total assets
-26.26%73K
-45.56%49K
-59.70%54K
-76.85%47K
-76.85%47K
-45.60%99K
-45.12%90K
-21.64%134K
-6.88%203K
-6.88%203K
Liabilities
Current liabilities
Current debt and capital lease obligation
----
----
----
----
----
----
----
----
21.70%2.47M
21.70%2.47M
-Current debt
----
----
----
----
----
----
----
----
21.70%2.47M
21.70%2.47M
-accounts payable
178.77%1.09M
-14.71%603K
92.88%1.27M
-17.70%493K
-17.70%493K
-57.82%391K
-55.22%707K
-53.39%660K
-59.14%599K
-59.14%599K
-Total tax payable
--0
--0
--0
---1K
---1K
--0
--0
--0
--0
--0
-Other payable
----
----
----
----
----
----
----
--1K
----
----
Current accrued expenses
28.98%365K
----
----
11.01%383K
11.01%383K
-37.11%283K
-46.04%266K
22.01%377K
-9.21%345K
-9.21%345K
Current liabilities
123.29%1.51M
-38.03%603K
-77.53%1.27M
-45.08%1.87M
-45.08%1.87M
-79.65%674K
-75.75%973K
50.61%5.67M
-11.93%3.41M
-11.93%3.41M
Non current liabilities
Non current accrued expenses
-5.56%34K
-2.56%38K
7.89%41K
-5.71%33K
-5.71%33K
-2.70%36K
-4.88%39K
-13.64%38K
-25.53%35K
-25.53%35K
Total non current liabilities
123.29%1.51M
-38.03%603K
-77.53%1.27M
-45.11%1.87M
-45.11%1.87M
-84.17%674K
-80.68%973K
12.35%5.67M
-37.49%3.41M
-37.49%3.41M
Shareholders'equity
Share capital
2.90%156.48M
1.77%154.75M
4.62%154.75M
3.09%152.07M
3.09%152.07M
5.66%152.07M
8.25%152.07M
5.60%147.92M
5.62%147.51M
5.62%147.51M
-common stock
2.90%156.48M
1.77%154.75M
4.62%154.75M
3.09%152.07M
3.09%152.07M
5.66%152.07M
8.25%152.07M
5.60%147.92M
5.62%147.51M
5.62%147.51M
Additional paid-in capital
11.41%46.56M
14.70%46.07M
16.20%44.81M
17.42%44.14M
17.42%44.14M
39.32%41.79M
44.11%40.16M
38.38%38.56M
34.89%37.59M
34.89%37.59M
Other equity interest
----
----
----
----
----
----
----
---38K
----
----
Total equity
-27.85%1.15M
-89.24%344K
-60.53%1.9M
-72.42%1.03M
-72.42%1.03M
-32.03%1.59M
238.67%3.2M
107.57%4.8M
-8.22%3.73M
-8.22%3.73M
(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023(Q1)Oct 31, 2022(FY)Jul 31, 2022(Q4)Jul 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -46.62%710K-95.75%120K-62.68%1.64M-75.15%808K-75.15%808K-29.33%1.33M499.58%2.82M134.76%4.4M-8.78%3.25M-8.78%3.25M
-Cash and cash equivalents -46.62%710K-95.75%120K-62.68%1.64M-75.15%808K-75.15%808K-29.33%1.33M499.58%2.82M134.76%4.4M-8.78%3.25M-8.78%3.25M
Total current assets -28.37%1.11M-90.31%306K-61.07%1.85M-73.04%996K-73.04%996K-32.48%1.55M250.11%3.16M109.87%4.76M-8.04%3.7M-8.04%3.7M
Non current assets
-Accumulated depreciation -0.84%-1.8M-0.78%-1.8M-----0.67%-1.79M-0.67%-1.79M-0.68%-1.79M-0.73%-1.79M-0.73%-1.78M-0.74%-1.78M-0.74%-1.78M
-Other intangible assets -68.31%2M-68.56%2.49M-60.35%3.72M-57.83%4.36M-57.83%4.36M-64.73%6.31M-60.37%7.9M-52.39%9.38M-47.36%10.34M-47.36%10.34M
Regulatory assets -22.81%88K-39.05%64K-53.69%69K-77.78%62K-77.78%62K-67.34%114K-67.08%105K-51.78%149K-20.96%279K-20.96%279K
Total assets -26.26%73K-45.56%49K-59.70%54K-76.85%47K-76.85%47K-45.60%99K-45.12%90K-21.64%134K-6.88%203K-6.88%203K
Liabilities
Current liabilities
Current debt and capital lease obligation --------------------------------21.70%2.47M21.70%2.47M
-Current debt --------------------------------21.70%2.47M21.70%2.47M
-accounts payable 178.77%1.09M-14.71%603K92.88%1.27M-17.70%493K-17.70%493K-57.82%391K-55.22%707K-53.39%660K-59.14%599K-59.14%599K
-Total tax payable --0--0--0---1K---1K--0--0--0--0--0
-Other payable ------------------------------1K--------
Current accrued expenses 28.98%365K--------11.01%383K11.01%383K-37.11%283K-46.04%266K22.01%377K-9.21%345K-9.21%345K
Current liabilities 123.29%1.51M-38.03%603K-77.53%1.27M-45.08%1.87M-45.08%1.87M-79.65%674K-75.75%973K50.61%5.67M-11.93%3.41M-11.93%3.41M
Non current liabilities
Non current accrued expenses -5.56%34K-2.56%38K7.89%41K-5.71%33K-5.71%33K-2.70%36K-4.88%39K-13.64%38K-25.53%35K-25.53%35K
Total non current liabilities 123.29%1.51M-38.03%603K-77.53%1.27M-45.11%1.87M-45.11%1.87M-84.17%674K-80.68%973K12.35%5.67M-37.49%3.41M-37.49%3.41M
Shareholders'equity
Share capital 2.90%156.48M1.77%154.75M4.62%154.75M3.09%152.07M3.09%152.07M5.66%152.07M8.25%152.07M5.60%147.92M5.62%147.51M5.62%147.51M
-common stock 2.90%156.48M1.77%154.75M4.62%154.75M3.09%152.07M3.09%152.07M5.66%152.07M8.25%152.07M5.60%147.92M5.62%147.51M5.62%147.51M
Additional paid-in capital 11.41%46.56M14.70%46.07M16.20%44.81M17.42%44.14M17.42%44.14M39.32%41.79M44.11%40.16M38.38%38.56M34.89%37.59M34.89%37.59M
Other equity interest -------------------------------38K--------
Total equity -27.85%1.15M-89.24%344K-60.53%1.9M-72.42%1.03M-72.42%1.03M-32.03%1.59M238.67%3.2M107.57%4.8M-8.22%3.73M-8.22%3.73M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg